Skip to main content
Clinical Trials/NCT01868308
NCT01868308
Completed
Not Applicable

Screening To Obviate Preterm Birth

University of Pennsylvania1 site in 1 country589 target enrollmentJanuary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preterm Labor
Sponsor
University of Pennsylvania
Enrollment
589
Locations
1
Primary Endpoint
Preterm birth
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Our objective is to investigate the predictive value of a panel of biomarkers associated with two biologically plausible pathways of preterm birth: membrane breakdown and cervical remodeling. The investigators will obtain cervical length, cervicovaginal fetal fibronectin, and a panel of novel cervicovaginal biomarkers associated with cervical remodeling in a prospective cohort of symptomatic women with a singleton pregnancy at high risk for preterm birth in an effort to better risk stratify this cohort.

Detailed Description

Preterm Birth is a complex syndrome for which several different biologically plausible pathways have been proposed, including mechanical uterine distension, abruption, inflammation, and/or activation of the fetal hypothalamic-pituitary-axis. However, despite our knowing the complexity of this syndrome and the different pathways involved, there is a paucity of clinical studies investigating whether detection of more than one of these pathways in a single patient might enhance the identification of those at greatest risk for preterm birth. We propose investigating the predictive value of a panel of biomarkers associated with two biological plausible pathways - membrane breakdown and cervical remodeling - that must be involved in the pathogenesis of preterm birth. Specifically, we propose measuring cervical length and collecting cervicovaginal fetal fibronectin as well as a panel of novel cervicovaginal biomarkers that reflect molecular pathways involved in cervical remodeling in a prospectively collected cohort of symptomatic women with singleton fetuses at high risk for preterm birth. Through this study we hope improve risk stratification of this high risk cohort.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
June 2015
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Singleton pregnancy between 22- 33 6/7 weeks of gestational age.
  • Must be experiencing one ore more of the following symptoms including but not limited to preterm contractions, abdominal cramping, back pain, vaginal pressure, or light vaginal bleeding.

Exclusion Criteria

  • Women with a multi-fetal pregnancy
  • Intra uterine fetal demise
  • Preterm premature rupture of membranes
  • Overt chorioamnionitis

Outcomes

Primary Outcomes

Preterm birth

Time Frame: Enrollment through delivery

The primary outcome is preterm birth defined as delivery before 37 weeks.

Secondary Outcomes

  • Early preterm birth(Enrollment through delivery)

Study Sites (1)

Loading locations...

Similar Trials